PARMAX PHARMA LTD.
|
Market Cap.(`)
|
15.08 Cr.
|
P/BV
|
-23.61
|
Book Value (`)
|
-1.71
|
|
52 Week High/Low ( ` )
|
54/25
|
FV/ML
|
10/1
|
P/E(X)
|
0.00
|
|
Book Closure
|
30/09/2024
|
EPS (`)
|
0.00
|
Div Yield (%)
|
0.00
|
(` in Crs.)
You can view the Standalone
Cash Flow
for the last 5 years.
| Months | 12 | 12 | 12 | 12 | 12 |
| Source Of Info (AR = Annual Report, PR = Press Release) | AR | AR | AR | AR | AR |
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| | | | | | |
| Net Profit/Loss Before Extraordinary Items And Tax | -5.66 | 0.05 | 0.30 | 1.21 | 0.73 |
| | | | | | |
| Net CashFlow From Operating Activities | -0.19 | 0.33 | 0.75 | 3.53 | 2.82 |
| Net Cash Used In Investing Activities | -1.59 | -0.94 | -1.53 | -3.15 | -2.40 |
| Net Cash Used From Financing Activities | 1.43 | -0.04 | -0.91 | 0.40 | -0.23 |
| | | | | | |
| Net Inc/Dec In Cash And Cash Equivalents | -0.35 | -0.65 | -1.69 | 0.78 | 0.20 |
| Cash And Cash Equivalents Begin of Year | 0.41 | 1.05 | 2.75 | 1.77 | 1.57 |
| Cash And Cash Equivalents End Of Year | 0.06 | 0.41 | 1.05 | 2.55 | 1.77 |